86 related articles for article (PubMed ID: 11058954)
1. [Specific regulatory inhibition of transfected HepG(2) with HCV 5'NCR by antisense phosphorothioate oligodeoxynucleotides].
Wang S; Wang X; Guan W; Li M
Zhonghua Gan Zang Bing Za Zhi; 2000 Oct; 8(5):288-90. PubMed ID: 11058954
[TBL] [Abstract][Full Text] [Related]
2. [The inhibitory effects of hepatocyte targeting pH-sensitive liposome mediated phosphorothioate antisense oligonucleotide on gene expression controlled by HCV 5'NCR].
Wang XH; Wang SQ; Wen SY; Guan W; Mao BZ
Sheng Wu Gong Cheng Xue Bao; 2001 Nov; 17(6):626-30. PubMed ID: 11910753
[TBL] [Abstract][Full Text] [Related]
3. [Inhibitory effects of phosphorothioate antisense oligonucleotides on gene expression controlled by HCV 5'NCR in nude mice xenograft].
Wang X; Wang S; Guan W; Mao B
Zhonghua Gan Zang Bing Za Zhi; 2001 Oct; 9(5):285-7. PubMed ID: 11676874
[TBL] [Abstract][Full Text] [Related]
4. Specific inhibition of hepatitis C viral gene expression by antisense phosphorothioate oligodeoxynucleotides.
Alt M; Renz R; Hofschneider PH; Paumgartner G; Caselmann WH
Hepatology; 1995 Sep; 22(3):707-17. PubMed ID: 7657273
[TBL] [Abstract][Full Text] [Related]
5. [The construction and evaluation of antisense RNA expression vector targeting at HCV 5'NCR].
Wang XH; Wang SQ; Guan W; Mao BZ
Sheng Wu Gong Cheng Xue Bao; 2001 Mar; 17(2):179-82. PubMed ID: 11411227
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of hepatitis C virus RNA translation by antisense bile acid conjugated phosphorothioate modified oligodeoxynucleotides (ODN).
González-Carmona MA; Quasdorff M; Vogt A; Tamke A; Yildiz Y; Hoffmann P; Lehmann T; Bartenschlager R; Engels JW; Kullak-Ublick GA; Sauerbruch T; Caselmann WH
Antiviral Res; 2013 Jan; 97(1):49-59. PubMed ID: 23142319
[TBL] [Abstract][Full Text] [Related]
7. Design and screening of antisense oligodeoxynucleotides against PAI-1 mRNA in endothelial cells in vitro.
Jiang QS; Wang SQ
Acta Pharmacol Sin; 2006 Aug; 27(8):1018-23. PubMed ID: 16867253
[TBL] [Abstract][Full Text] [Related]
8. [5'NCR Incipient establishment of HCV 5'NCR transgenic mice model].
Wang X; Guo P; Guan W; Cheng Y; Wang S
Zhonghua Gan Zang Bing Za Zhi; 2002 Feb; 10(1):37-9. PubMed ID: 11856501
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of hepatitis C virus gene expression by adenoviral vectors encoding antisense RNA in vitro and in vivo.
González-Carmona MA; Vogt A; Heinicke T; Quasdorff M; Hoffmann P; Yildiz Y; Schneider C; Serwe M; Bartenschlager R; Sauerbruch T; Caselmann WH
J Hepatol; 2011 Jul; 55(1):19-28. PubMed ID: 21145870
[TBL] [Abstract][Full Text] [Related]
10. [Expression of secreted alkaline phosphatase in hepatocytes controlled by HCV IRES].
Liu SP; Tan DM; Hou ZH
Hunan Yi Ke Da Xue Xue Bao; 2003 Aug; 28(4):335-7. PubMed ID: 14653111
[TBL] [Abstract][Full Text] [Related]
11. [Inhibitory effect of replication and expression of HDV by antisense oligodeoxynucleotides in H1 delta 9 cell].
Li H; Mao Q; Li Q
Zhonghua Gan Zang Bing Za Zhi; 1999 Mar; 7(1):13-4. PubMed ID: 10366975
[TBL] [Abstract][Full Text] [Related]
12. Specific in vitro association between the hepatitis C viral genome and core protein.
Fan Z; Yang QR; Twu JS; Sherker AH
J Med Virol; 1999 Oct; 59(2):131-4. PubMed ID: 10459145
[TBL] [Abstract][Full Text] [Related]
13. [Inhibition of hepatitis C virus gene expression by antisense nucleotide in vitro].
Li YN; Yu M; Wu WQ; Gao JX; Wang H; Ji SP; Wang QH; Si CW
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2004 Dec; 18(4):341-3. PubMed ID: 15650784
[TBL] [Abstract][Full Text] [Related]
14. Virological effects of ISIS 14803, an antisense oligonucleotide inhibitor of hepatitis C virus (HCV) internal ribosome entry site (IRES), on HCV IRES in chronic hepatitis C patients and examination of the potential role of primary and secondary HCV resistance in the outcome of treatment.
Soler M; McHutchison JG; Kwoh TJ; Dorr FA; Pawlotsky JM
Antivir Ther; 2004 Dec; 9(6):953-68. PubMed ID: 15651754
[TBL] [Abstract][Full Text] [Related]
15. [Inhibition of hepatitis C virus by antisense oligodeoxynucleotide in vitro].
Liu Y; Chen Z; He N
Zhonghua Yi Xue Za Zhi; 1997 Aug; 77(8):567-70. PubMed ID: 9772458
[TBL] [Abstract][Full Text] [Related]
16. [Establishment and the significance of a cell model of secreted alkaline phosphatase co-controlled by HCV 5'NCR and NS3 serine protease].
Liu SP; Tan DM; Yang YF; Hou ZH
Zhonghua Gan Zang Bing Za Zhi; 2004 Sep; 12(9):552-3. PubMed ID: 15387910
[TBL] [Abstract][Full Text] [Related]
17. [Effect of structural domain II of HCV 5' noncoding region on its translation initiation activity].
Liu SP; Zhao JQ; Li HT; Yang T
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2009 Jun; 23(3):200-3. PubMed ID: 20104778
[TBL] [Abstract][Full Text] [Related]
18. Variation of the hepatitis C virus 5' non-coding region: implications for secondary structure, virus detection and typing. The International HCV Collaborative Study Group.
Smith DB; Mellor J; Jarvis LM; Davidson F; Kolberg J; Urdea M; Yap PL; Simmonds P
J Gen Virol; 1995 Jul; 76 ( Pt 7)():1749-61. PubMed ID: 9049380
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of hepatitis C virus-transfected cholangiocarcinoma by antisense oligodeoxynucleotide in nude mice.
Liu XF; Zhou XT; Zou SQ
Hepatobiliary Pancreat Dis Int; 2004 Feb; 3(1):115-9. PubMed ID: 14969852
[TBL] [Abstract][Full Text] [Related]
20. [Inhibition of genomic HDV ribozyme activity by antisense oligodeoxynucleotides].
Mao Q; Wang S; Li Q
Zhonghua Yi Xue Za Zhi; 1996 Jan; 76(1):30-3. PubMed ID: 8758460
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
